• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Free drug samples may alter prescription habits of dermatologists

byShirin BajajandAdam Whittington
April 21, 2014
in Chronic Disease, Dermatology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. For treatment of acne vulgaris, 79% of nationwide prescriptions were written for brand-name generic and brand-name drugs, whereas a large academic medical center (LAMC) that banned samples only had 17%. 

2. In the case of an office-visit for acne, the utilization of branded and branded-generic drugs nationwide translated to an increased retail cost of $465 vs. $200 at a LAMC. 

Evidence Rating Level: 2 (Good)

Study Rundown: Theoretically, free drug samples offer patients the opportunity to try an expensive drug without shouldering the expense. However, studies have documented that samples often aren’t provided to patients who would financially benefit from their usage, and furthermore that free samples may influence the prescribing patterns of physicians. This study sought to investigate whether the provision of free medication samples affects the prescribing behavior of dermatologists associated with acne vulgaris and rosacea.  This study compared national data on prescribing patterns, in which free samples are thought to be ubiquitous, with the prescribing patterns for the same conditions at a large academic medical center (LAMC), at which free samples have been banned. On a national-level, this study showed that prescription patterns of brand-name drugs and brand-name generics have increased and were correlated with increased provision of samples of these drugs. A strength of this study was the inclusion of pooled data from two national databases. However, limitations exist. The authors did not look into other forms of marketing that may influence physicians, including visits from pharmaceutical representatives and co-payment discount cards. Furthermore there was no multivariate regression analysis to account for the different demographics of patients seen at the LAMC, which consisted of a reported larger Medicare and Medicaid population as compared to those seen in national practice.  Such a difference may have the potential to influence the choice of brand-name vs. generic medication.

Click to read the study in JAMA Dermatology

RELATED REPORTS

Increased tirzepatide use for glycemic and weight control since United States market entry

Semaglutide may aid tobacco cessation in patients with comorbid diabetes

Relevant Reading: Drug Samples in Dermatology: Out of the Closet, Into the Dustbin

In-Depth [cross-sectional study]: The study pooled national data on prescriptions for acne vulgaris and rosacea, two of the most common dermatologic conditions, from the National Disease and Therapeutic Index (NDTI), a survey of US physicians that provides nationally representative information on diagnosis and treatment of various diseases and compared this with prescriptions of medications for the same treatments at a LAMC that banned free drug samples. Analysis of NDTI showed the overall percentage of samples provided to dermatologic patients increased from 12% in 2001 to 18% in 2010, as compared to the composite decrease of free samples prescribed from other specialties, which was down to 4% in 2010 from 7% in 2001. For acne vulgaris particularly, NDTI data showed free samples increased from 10% in 2001 to 25% in 2010. Using Pearson product moment correlation they analyzed the relationship between sample availability and the proportion of branded-generic prescriptions written. There was strong correlation between the most frequently prescribed acne medications and those commonly prescribed with samples (r=0.92). 9 of the 10 most popular drugs prescribed for acne nationwide in 2010 were brand-name generics, as compared to the LAMC, at which 9 of the 10 most popular acne drugs were generic drugs.

More from this author: Teledermatology may be reliable in triaging inpatient dermatology consultations, Atopic dermatitis may be more persistent than previously understood 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: prescriptions
Previous Post

Receptor responsible for fertilization discovered

Next Post

Trivalent influenza vaccine effective in children under age 2

RelatedReports

Prescription medicines collage: a mortar and pestle, a blister pack of white tablets, teal capsules and a glass beaker
Chronic Disease

Increased tirzepatide use for glycemic and weight control since United States market entry

April 14, 2025
Quitting smoking collage: a globe, a cigarette snapped in two beside a plain pack, and a seedling in a pot
Pharma

Semaglutide may aid tobacco cessation in patients with comorbid diabetes

January 22, 2025
Chronic Disease

Incorporating pharmacists into kidney care model may reduce inappropriate prescription rates

September 3, 2020
Chronic Disease

Academic medical center detailing policies impact physician prescribing

May 7, 2017
Next Post

Trivalent influenza vaccine effective in children under age 2

Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Home oxygen treatment for mild bronchiolitis explored

2 Minute Medicine Rewind April 14 – April 20, 2014

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
  • CDC reports 5,412 confirmed measles cases in the United States in 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.